Details
The California SCC Chapter is going virtual with our October Scientific Seminar!!!
As we cannot be together in person, we want to offer this amazing program in conjunction with national SCC over a 2-week period. The Scientific Seminar will feature 2 speakers, both on Fridays in October.
On 10/2 at 10am PST, we are excited to have Dr. Alexander Lorestani, PhD – CEO at Gelltor as our speaker:
Cosmetics and personal care formulators are embracing the power of biology to incorporate advanced consumer proteins, from sustainable, certified-vegan marine collagen to biocompatible human elastin for topical skincare. In this Technical Seminar, Dr. Alex Lorestani will introduce the science behind novel bio-designed ingredients, including efficacy data and formulation testing.
On 10/9 at 10am PST, we are excited to have Dr. Hyder Aliyar, PhD - Research Investigator at DuPont as our speaker:
Silicone pressure sensitive adhesives demonstrated their efficacy and performance in transdermal drug delivery as evidenced by the number of commercial transdermal patch products in the market. Recent technologies like swollen crosslinked silicone elastomer blend networks and silicone-acrylic hybrid pressure sensitive adhesives promise potential performance advantages and improved drug delivery efficacy. This presentation provides an overview of several types of silicone technologies and their function as excipients enabling efficient drug delivery for skin.
WHO SHOULD ATTEND:
This webinar series is open to all SCC members and is recommended for anyone interested in new and novel skin care technologies. The CA SCC intent is that this 2 day webinar serve as our Virtual Scientific Seminar. So if you are looking to see “what’s next” in skin care, this series is for you.
Speakers
Presenting first, on Friday, October 2nd, 2020:

Speaker: Dr. Alexander Lorestani
Title: Building Beauty with Biology
Abstract: Cosmetics and personal care formulators are embracing the power of biology to incorporate advanced consumer proteins, from sustainable, certified-vegan marine collagen to biocompatible human elastin for topical skincare. In this Technical Seminar, Geltor CEO and co-founder Alex Lorestani, PhD will introduce the science behind novel biodesigned ingredients, including efficacy data and formulation testing.
Bio: Alex Lorestani is co-founder and CEO of Geltor, the conscious biodesign company that has created the largest selection of 100% animal-free, globally scalable, and sustainably cultivated designer proteins. He is strongly motivated by the positive impact that Geltor’s protein design and production technology can have on public health, sustainability, and user experience. The company has been recognized for its innovation and leadership by industry leaders including CEW, the Personal Care Products Council, Society of Cosmetic Chemists, and ICMAD Indie Beauty Innovators Awards
Alex became interested in transforming the global protein supply chain as an MD/Ph.D. student working to solve antibiotic resistance. He studied Medicine at Rutgers University, earned a Ph.D. in Molecular Biology from Princeton University, and holds a BS in Biology from Boston College.
Presenting on Friday, October 9th, 2020:

Speaker: Dr. Hyder Aliyar
Title: Efficient Drug Delivery for Skin Enabled by Silicone Technologies
Abstract:
Silicones have been used in medical and cosmetic applications for over 60 years. Polydimethylsiloxanes are primary silicone polymers that are typically used as excipients in topical and transdermal drug products in delivering drug to or through the skin. Inherent characteristics like hydrophobicity, low surface tension, polymer chain flexibility, and low intermolecular interaction allow silicones to offer function and performance to drug products. Silicone pressure sensitive adhesives demonstrated their efficacy and performance in transdermal drug delivery as evidenced by the number of commercial transdermal patch products in the market. Recent technologies like swollen crosslinked silicone elastomer blend networks and silicone-acrylic hybrid pressure sensitive adhesives promise potential performance advantages and improved drug delivery efficacy. This presentation provides an overview of several types of silicone technologies and their function as excipients enabling efficient drug delivery for skin.
Bio:
Hyder is working as a Research Investigator in the Medical Silicones group of Transportation and Industrial division in DuPont. At work, his focus is to investigate and evaluate silicone technologies to product development for drug delivery and skin care. Design and development of efficient drug delivery formulations for skin is one of his key interests. He has a PhD in Polymer Science from University of Madras, India. For the last 20+ years, he has gained research and product development experience via working in research institutes, universities and industry both in Japan and US, all almost on polymeric materials for medical device and drug delivery. Prior to DuPont, he was at Dow Corning and subsequently at Dow.